Lupin Limited has informed the Exchange regarding a press release dated January 06, 2023, titled "Lupin Receives Approval from U.S. FDA for Fesoterodine Fumarate Extended-ReleaseTablets.".
Lupin Limited has informed the Exchange regarding a press release dated January 06, 2023, titled "Lupin Receives Approval from U.S. FDA for Fesoterodine Fumarate Extended-ReleaseTablets.".